Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
American Academy of Pediatrics
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
15
item.page.accessRights
item.page.other
item.page.references
Abstract
OBJECTIVES:
The overall safety profile of the 9-valent human papillomavirus (9vHPV) vaccine was evaluated across 7 Phase III studies, conducted in males and females (nonpregnant at entry), 9 to 26 yea...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Pediatrics. 2016 Aug;138(2). pii: e20154387
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026